1-8 of 8
Houli Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Generation of Anti-CD7 Universal CAR-T Therapy for Patients with Relapsed or Refractory CD7 Positive T-ALL/Lbl: A Phase I Clinical Trial

Yongxian Hu, Yali Zhou, Mingming Zhang, Shan Fu, Yong Yu, Ming Gao, Ruimin Hong, Houli Zhao, Lu Han, Jiangtao Ren, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 921.
https://doi.org/10.1182/blood-2024-207322
Published: 2024
Journal Articles

Clinical Characteristics and Outcomes of BCMA-Targeted CAR-T Cell Recipients with Coronavirus Disease 2019 during the Omicron Wave: A Retrospective Study

Haiqiong Zheng, Shi Han, Houli Zhao, Yongxian Hu, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 5170.1.
https://doi.org/10.1182/blood-2024-207233
Published: 2024
Journal Articles

Neither Conditioning Chemotherapy Nor GvHD-Prophylaxis: CD7 CAR-T Treatment Bridging to Haplo-HSCT

Yongxian Hu, Mingming Zhang, Tingting Yang, Ruirui Jing, Houli Zhao, Rongrong Chen, Tianning Gu, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Delin Kong, Huijun Xu, Jiazhen Cui, Simao Huang, Bin Liang, Guoqing Wei, Xiaolin Yuan, Qu Cui, Jiangtao Ren, Alex H. Chang, Dongrui Wang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1039.
https://doi.org/10.1182/blood-2023-185697
Published: 2023
Journal Articles

A Multi-Omic Single-Cell Landscape of Cytokine Release Syndrome in Multiple Myeloma Patients after Anti-BCMA CAR-T Cell Therapy

Yongxian HU, Xia Li, Penglei Jiang, Tingting Yang, Tianning Gu, Xiaohui Si, Yali Xie, Mingming Zhang, Guoqing Wei, Huijun Xu, Zenan Cen, Jiazhen Cui, Simao Huang, Fang Ni, Linqin Wang, Xiujian Wang, Xiangjun Zeng, Delin Kong, Houli Zhao, Alex H. Chang, Yanlei Zhang, Jin Zhang, Jinyan Huang, Pengxu Qian, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 101.
https://doi.org/10.1182/blood-2023-185236
Published: 2023
Journal Articles

Genomic and Transcriptomic Profiling Reveal the Mechanism and Risk Factors of CD19-Negative Relapse after CAR-T Cell Therapy

Ruimin Hong, Linghui Zhou, Ye Meng, Mingming Zhang, Houli Zhao, Jiazhen Cui, Simao Huang, Yongxian Hu, He Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 6354–6355.
https://doi.org/10.1182/blood-2022-164955
Published: 2022
Journal Articles

Predictive Value of Next-Generation Sequencing-Based Minimal Residual Disease after CAR-T Cell Therapy

Yue Huang, Houli Zhao, Mi Shao, Linghui Zhou, Guoqing Wei, Wenjun Wu, Alex Hong Chang, Tao Sun, Yongxian HU, He Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2842.
https://doi.org/10.1182/blood-2021-149928
Published: 2021
Journal Articles

CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study

Yongxian Hu, MD, Yanlei Zhang, Houli Zhao, MD, Yiyun Wang, Arnon Nagler, MD, Alex Hong Chang, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-143239
Published: 2020
Journal Articles

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

Ruimin Hong, Houli Zhao, MD, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, MD, Guoqing Wei, MD, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-139007
Published: 2020